Heterotopic ossification after the use of commercially available recombinant human bone morphogenetic proteins in four patients

Abstract excerpt

Heterotopic ossification occurring after the use of commercially available bone morphogenetic proteins has not been widely reported. We describe four cases of heterotopic ossification in patients treated with either recombinant bone morphogenetic protein 2 or recombinant bone morphogenetic protein 7. We found that while some patients were asymptomatic, heterotopic ossification which had occurred around a joint...

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to Bone Tumor Diagnosis and Treatments
• Share to Heterotopic Ossification and Related Conditions
• Share to Medical Imaging and Pathology Studies